Joypretty Polypeptidemulti-Effectseye Cream

Manufacturer
Guangzhou Bonnieco Cosmetics Co., Ltd
Effective date
2024-04-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:10:32

Label at a glance#

ProductJoypretty Polypeptidemulti-Effectseye Cream
Active ingredientPROPYLENE GLYCOL
Label structure13 sections

Dosage and administration

1.After cleaning skin,apply appropriateamount of PolypeptideMulti-Effects EyeCream on the skinaround eyes; 2.Gently tap the skinwith your fingertip tohelp absorption.

Storage and handling

Store in a cool and dry place

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

PROPYLENE GLYCOL 6%

Purpose

OTC - PURPOSE SECTION

skin conditioner

Use

INDICATIONS & USAGE SECTION

Wrinkle removal Lightening dark circle

Warnings

WARNINGS SECTION

For external use only. Keep out ofreach of childre

Do not use

OTC - DO NOT USE SECTION

the arm first. Discontinue use ifsigns of irritation or rash occurand seek the assistance of adermatologist.

When Using

OTC - WHEN USING SECTION

In case of contact with the eyes, rinse immediately with plenty of water.

Stop Use

OTC - STOP USE SECTION

If discomfort arises, please immediately stop using the product and seek the assistance of a dermatologist.

Ask Doctor

OTC - ASK DOCTOR SECTION

If discomfort arises, please immediately stop using the product and seek the assistance of a dermatologist.

Keep Oot Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed call emergency services.

Directions

DOSAGE & ADMINISTRATION SECTION

1.After cleaning skin,apply appropriateamount of PolypeptideMulti-Effects EyeCream on the skinaround eyes; 2.Gently tap the skinwith your fingertip tohelp absorption.

Other information

STORAGE AND HANDLING SECTION

Store in a cool and dry place

Inactive ingredients

INACTIVE INGREDIENT SECTION

WATER, PROPYLENE GLYCOL, CETEARYL GLUCOSIDE, SORBITAN OLIVATE, SQUALANE, ISOHEXADECANE, CETEARYL ALCOHOL, DIMETHICONE, OLIGOPEPTIDE-1, ACETYL HEXAPEPTIDE-8, ACETYL TETRAPEPTIDE-5, CYCLOMETHICONE, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, PORTULACA OLERACEA EXTRACT, ALLANTOIN, HYDROXYACETOPHENONE, 1,2-HEXANEDIOL

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

1122

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
84186-008-012025-07-29C16284748780-13b156c62-3304-fb37-e063-e6dba90a4e0784186-008

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84186-008-01Joypretty Polypeptidemulti-Effectseye Cream20 g in 1 TUBECREAM201

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84186-008JOYPRETTY POLYPEPTIDEMULTI-EFFECTSEYE CREAM (POLYPEPTIDEMULTI-EFFECTSEYE CREAM) CREAM [GUANGZHOU BONNIECO COSMETICS CO., LTD]11 package rows20240403_1514e255-5e84-a6fc-e063-6394a90a7015.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84186-00884186-008-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1514e255-5e85-a6fc-e063-6394a90a70151514e255-5e84-a6fc-e063-6394a90a70152024-04-01WarningsExact identifier
spl id: 1514e255-5e85-a6fc-e063-6394a90a7015
spl set id: 1514e255-5e84-a6fc-e063-6394a90a7015

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.